Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic protein Scios Inc, Brown University, Amgen Clinical Immunology (2007). [ISPRI prediction of immunogenicity]
Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic protein
by epivax3 | Oct 22, 2016 | 0 comments
